Company profile for Menarini

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

The Menarini Group is present in 136 countries worldwide, a guarantee of internationally recognised quality. The achieved results are proof of an efficient strategy based on Research, Innovation and Internationalisation, along with the ability to recognize and meet the needs of physicians and patients alike. One of the Menarini Group's strong points is its collaboration with international partners: the goal is to create syn...
The Menarini Group is present in 136 countries worldwide, a guarantee of internationally recognised quality. The achieved results are proof of an efficient strategy based on Research, Innovation and Internationalisation, along with the ability to recognize and meet the needs of physicians and patients alike. One of the Menarini Group's strong points is its collaboration with international partners: the goal is to create synergies that give rise to cutting-edge solutions, pharmaceutical products, and services in the health sector. At Menarini, quality is the basis of a shared Group strategy.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Italy
Address
Address
Via Dei Sette Santi 1/3 50131 Firenze Italia
Telephone
Telephone
(055) 56.80.1
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/the-volpi-rosse-menarini-the-fantastic-ten-are-ready-for-the-2025---2026-season-302624579.html

PR NEWSWIRE
24 Nov 2025

https://www.prnewswire.com/news-releases/menarini-group-announces-new-data-on-elzonris-tagraxofusp-erzs-to-be-presented-at-the-67th-american-society-of-hematology-annual-meeting-and-exposition-302624638.html

PR NEWSWIRE
24 Nov 2025

https://www.prnewswire.com/news-releases/menarini-groups-obicetrapib-and-obicetrapibezetimibe-marketing-authorisation-applications-accepted-for-review-by-the-european-medicines-agency-ema-for-the-treatment-of-adults-with-primary-hypercholesterolaemia-heterozygous-fa-302543737.html

PR NEWSWIRE
02 Sep 2025

https://www.prnewswire.com/news-releases/fair-play-menarini-international-award-luis-figo-joins-the-great-sports-stars-acknowledged-in-2025-302495568.html

PR NEWSWIRE
01 Jul 2025

https://www.globenewswire.com/news-release/2025/05/22/3087170/21662/en/Menarini-Group-Presents-Updated-Data-Underscoring-the-Combinability-of-Elacestrant-ORSERDU-in-Patients-with-ER-HER2-Metastatic-Breast-Cancer-mBC-at-the-ASCO-2025-Annual-Meeting.html

GLOBENEWSWIRE
22 May 2025

https://www.prnewswire.com/news-releases/erbc-and-menarini-biotech-join-forces-to-accelerate-the-development-of-biopharmaceuticals-from-research-to-first-in-human-clinical-trials-302419863.html

PR NEWSWIRE
03 Apr 2025

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty